You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

Litigation Details for Sunovion Pharmaceuticals v. Dey Pharma (D. Del. 2006)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Sunovion Pharmaceuticals v. Dey Pharma (D. Del. 2006)

Docket   Start Trial Date Filed 2006-02-22
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Both Referred To
Patents 4,375,547; 4,404,216; 4,687,777; 4,760,075; 5,286,497; 5,362,755; 5,439,689; 5,470,584; 5,547,994; 5,576,328; 5,760,090; 5,795,564; 5,844,002; 6,083,993; 6,451,289
Attorneys Andrew Colin Mayo; Ashley Blake Stitzer; David E. Wilks; David Ellis Moore; Edgar H. Haug; Elizabeth A. Leff; Jack B. Blumenfeld; Jack M. Stover; Jayson R. Wolfgang; John G. Day; John Goetz; Karen Jacobs Louden; Kimberly J. McGraw; Richard D. Kirk; Richard K. Herrmann; Richard L. Horwitz; Sam V. Desai; Steven J. Balick; Susan M. Dadio; Tiffany Geyer Lydon; Todd R. Walters
Link to Docket External link to docket
Small Molecule Drugs cited in Sunovion Pharmaceuticals v. Dey Pharma
Biologic Drugs cited in Sunovion Pharmaceuticals v. Dey Pharma
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Sunovion Pharmaceuticals v. Dey Pharma (D. Del. 2006)

Date Filed Document No. Description Snippet Link To Document
2007-02-08 100 Notice (Other) All documents and things relating to U.S. Patent No. 5,795,564 or the subject matter disclosed therein.…Things All documents and things relating to U.S. Patent Nos. 5,362,755; 5,547,994; 5,760,090; 5,844,002…applications leading to the allowance of these patents. All documents and things including, but not limited… 1996, which was submitted to the United States Patent and Trademark Office. All documents relating to…declaration that was submitted to the United States Patent and Trademark Offrce. All documents and things External link to document
2006-11-15 17 Reply Brief and unrelated formulation patent—U.S. Patent No. 6,451,289 (the ’289 patent)— against Breath. (A copy… an existing patent from being used to extend the patent term of that existing patent by disclaiming…not. Second, the patents asserted in Dey I and Dey II are different than the patents asserted in the Breath…Dey II, five method-of-use patents are asserted against Dey. All five patents are related and have the… the Breath action six patents are asserted. In addition to the five patents asserted against Dey, Sepracor External link to document
2006-07-07 21 Opening Brief in Support beneficiai owncr, respectively, of U.S. Patent No. 4`404.216 (the “ ’216 oatent”} l"or an antifungai…owner of U.S. Patent No. 4,847,265 ttlie “265 Patent”i and No` 5,576,328 flying “3?.8 Patent”)_. The 265… in a patent or the use of which is ciairned in a patent before the expiration of such a patent‘” §_5_…This action for patent infringement arises under the Drug Price Cornpetition and Patent Terrn Restoration…notify the patent holder. Id. at 589 (citing 21 U.S.C. § 355()`)(2)(b)(i)). "'l`he patent holder External link to document
2008-02-25 255 Answering Brief in Opposition asserting the method-of-use patents along with a sixth patent, U.S. Patent No. 6,451,289, which claims formulations…filed the instant action for infringement ofU.S. Patent Nos. 5,362,755, 5,547,994, 5,760,090, 5,844,0025,844,002 and 6,083,993 (“the method-of-use patents”) against Defendants Dey, L.P. and Dey, Inc. (collectively…solutions”), Dey has infringed the method-of-use patents. Subsequently, Dey filed a second ANDA seeking … constitutes infringement of the method-of-use patents. These two actions were consolidated by Judge Jordan External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.